Literature DB >> 25651370

Association of HLA-DR/DQ polymorphism with Alzheimer's disease.

Leila Mansouri1, Mariem Messalmani, Sarra Klai, Ines Bedoui, Hajer Derbali, Nasreddine Gritli, Ridha Mrissa, Najiba Fekih-Mrissa.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is a complex disorder, resulting from an interaction between environmental and genetic factors. Several studies have addressed the association of AD with major histocompatibility complex (MHC) polymorphisms without arriving at any definite conclusions. The human leukocyte antigen (HLA) region is the key susceptibility locus in many immunological diseases. The aim of this study was to investigate the probable association between HLA-DR/DQ alleles and AD in Tunisian patients.
METHODS: HLA-DR/DQ genotyping was performed using polymerase chain reaction sequence-specific primers with 55 AD patients and 100 healthy individuals serving as the control group.
RESULTS: AD in Tunisian patients was found to be associated with the following alleles (Pc denotes Bonferroni corrected probability values): HLA-DRB1*15 (Pc < 10-3), DRB1*04 (Pc = 0.03) and DQB1*06 (Pc < 10-3). Two haplotypes found to be associated with the disease were DRB1*1501/DQB1*0602 (Pc < 10-3) and DRB1*0402/DQB1*0302 (Pc = 0.02).
CONCLUSIONS: The authors believe this to be the first research linking the haplotypes DRB1*1501/DQB1*0602 and DRB1*04/DQB1*0302 with AD. Larger studies in other populations will be important to support the present findings of the possible susceptible risk of HLA-DR/DQ in AD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25651370     DOI: 10.1097/MAJ.0000000000000416

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Effects of HLA-DRB1/DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer's Disease Cohorts.

Authors:  Zi-Xuan Wang; Hui-Fu Wang; Lin Tan; Jinyuan Liu; Yu Wan; Fu-Rong Sun; Meng-Shan Tan; Chen-Chen Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-04-07       Impact factor: 5.590

2.  Pharmacogenetic and Association Studies on the Influence of HLA Alleles and Rivastigmine on the Iranian Patients with Late-Onset Alzheimer's Disease.

Authors:  Fatemeh Rezaei Rad; Masood Ghahvechi Akbari; Majid Zamani; Shiva Bayat; Mahdi Zamani
Journal:  Mol Neurobiol       Date:  2021-01-27       Impact factor: 5.590

3.  Accounting for nonlinear effects of gene expression identifies additional associated genes in transcriptome-wide association studies.

Authors:  Zhaotong Lin; Haoran Xue; Mykhaylo M Malakhov; Katherine A Knutson; Wei Pan
Journal:  Hum Mol Genet       Date:  2022-07-21       Impact factor: 5.121

4.  Study on the association of the polymorphism of HLA-II gene with leukemia.

Authors:  Jiang Wu; Yu Song; Fei Chen; Hui Xiao
Journal:  Oncol Lett       Date:  2017-05-08       Impact factor: 2.967

5.  Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.

Authors:  Natasha Z R Steele; Jessie S Carr; Luke W Bonham; Ethan G Geier; Vincent Damotte; Zachary A Miller; Rahul S Desikan; Kevin L Boehme; Shubhabrata Mukherjee; Paul K Crane; John S K Kauwe; Joel H Kramer; Bruce L Miller; Giovanni Coppola; Jill A Hollenbach; Yadong Huang; Jennifer S Yokoyama
Journal:  PLoS Med       Date:  2017-03-28       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.